Holen Sie sich die Stockscreener-App
1.31
1.94%
0.02
Handel nachbörslich:
1.31
Schlusskurs vom Vortag:
$1.29
Offen:
$1.27
24-Stunden-Volumen:
556.44K
Relative Volume:
0.44
Marktkapitalisierung:
$500.41M
Einnahmen:
$106.34M
Nettoeinkommen (Verlust:
$-74.66M
KGV:
-1.3789
EPS:
-0.95
Netto-Cashflow:
$-46.12M
1W Leistung:
+1.15%
1M Leistung:
+1.94%
6M Leistung:
+14.35%
1J Leistung:
-30.42%
1-Tages-Spanne:
$1.27
$1.33
1-Wochen-Bereich:
$1.27
$1.37
52-Wochen-Spanne:
$0.92
$2.32
Standard Biotools Inc Stock (LAB) Company Profile
Firmenname
Standard Biotools Inc
Sektor
Branche
Telefon
(650) 266-6000
Adresse
2 TOWER PLACE, SOUTH SAN FRANCISCO
Vergleichen Sie LAB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LAB
Standard Biotools Inc
|
1.31 | 488.95M | 106.34M | -74.66M | -46.12M | -0.95 |
|
ABT
Abbott Laboratories
|
133.26 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
369.88 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.53 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.35 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Standard Biotools Inc Stock (LAB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-13 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-27 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-04-16 | Eingeleitet | TD Cowen | Buy |
| 2024-04-04 | Eingeleitet | Jefferies | Buy |
| 2023-07-12 | Eingeleitet | KeyBanc Capital Markets | Overweight |
Standard Biotools Inc Aktie (LAB) Neueste Nachrichten
How Standard BioTools Inc. stock compares to growth peers2025 Trading Recap & Scalable Portfolio Growth Methods - newser.com
Can Standard BioTools Inc. hit a new high this monthEarnings Trend Report & Growth Focused Stock Pick Reports - newser.com
Is Standard BioTools Inc. stock cheap compared to fundamentalsMarket Sentiment Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Applying sector rotation models to Standard BioTools Inc.Quarterly Profit Report & AI Based Buy/Sell Signal Reports - newser.com
What dividend safety rating applies to Standard BioTools Inc. (FLB) stockJuly 2025 Momentum & Weekly Stock Performance Updates - newser.com
How high can Standard BioTools Inc. stock goWeekly Investment Summary & AI Forecasted Entry and Exit Points - newser.com
Standard BioTools Inc. (LAB) Investor Outlook: 30% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Standard BioTools cut to Neutral at KeyBanc on guidance - MSN
Can swing trading help recover from Standard BioTools Inc. lossesGold Moves & AI Forecast for Swing Trade Picks - newser.com
Standard BioTools' (LAB) Sell (D-) Rating Reiterated at Weiss Ratings - MarketBeat
Standard BioTools’ (LAB) Sell (D-) Rating Reiterated at Weiss Ratings - Defense World
What recovery options are there for Standard BioTools Inc.Take Profit & Verified Entry Point Signals - newser.com
Will a bounce in Standard BioTools Inc. offer an exitInsider Buying & Accurate Entry/Exit Alerts - newser.com
Is Standard BioTools Inc a good long term investmentSwing Trading Watchlist & Invest Now – Opportunity Window Closing - earlytimes.in
Is Standard BioTools Inc FLB a good long term investmentEconomic Impact on Stocks & Access Our Free Weekly Investment Letter - earlytimes.in
Standard BioTools Inc Stock Analysis and ForecastStock Valuation Metrics & Free Unlock Exclusive Strategies - earlytimes.in
What drives Standard BioTools Inc stock priceSupport Level Holds & Low Cost Stock Picks - earlytimes.in
What analysts say about Standard BioTools Inc stockStock Buyback Announcements & Minimal Investment Profits - earlytimes.in
What analysts say about Standard BioTools Inc FLB stockBlue Chip Stock Analysis & Exceptional Profit Trading - earlytimes.in
Standard BioTools jumps on sale of SomaLogic to Illumina - MSN
Goldman Sachs Group Inc. Cuts Stock Position in Standard BioTools Inc. $LAB - MarketBeat
Portfolio Shifts: Will Standard BioTools Inc. face regulatory challengesVolume Spike & Fast Exit and Entry Strategy Plans - خودرو بانک
Earnings Miss: Can Standard BioTools Inc scale operations efficientlyJuly 2025 Closing Moves & Safe Entry Momentum Tips - خودرو بانک
Volatility Watch: Is RFPRFs ROIC above industry averageQuarterly Earnings Summary & Verified Short-Term Trading Plans - khodrobank.com
Pacific Capital Partners Ltd Sells 200,000 Shares of Standard BioTools Inc. $LAB - MarketBeat
Buyback Watch: How does Standard BioTools Inc correlate with NasdaqTrade Risk Assessment & Fast Entry Momentum Alerts - خودرو بانک
ETF Watch: Is Standard BioTools Inc impacted by rising ratesWeekly Trend Report & Weekly Stock Breakout Alerts - خودرو بانک
CEO Change: Is Standard BioTools Inc impacted by rising ratesStop Loss & Reliable Volume Spike Alerts - خودرو بانک
Breakout Watch: Is APPS a strong candidate for buy and holdM&A Rumor & High Accuracy Swing Entry Alerts - خودرو بانک
Standard BioTools announces workforce reduction and restructuring plan By Investing.com - Investing.com Canada
Standard BioTools announces workforce reduction and restructuring plan - Investing.com India
Finanzdaten der Standard Biotools Inc-Aktie (LAB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.22%
1.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):